Poor agreement between dipyridamole-stress technetium-99m-tetrofosmin myocardial perfusion single photon emission computed tomography and two-dimensional echocardiography in Kawasaki disease

International Journal of Cardiology

Volumn 90, Issue 1, 2003, Pages 57-61

  Fu, Y C ^a,e   Liu, F Y ^b   Tsai, S C ^c   Hwang, B ^d,e   Chi, C S ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cardiac involvement; Children; Echocardiography; Kawasaki disease; Non invasive diagnosis

Indexed keywords

AMINOPHYLLINE; DIPYRIDAMOLE; TETROFOSMIN TC 99M;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HUMAN; INFANT; INTERMETHOD COMPARISON; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; REST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0038719654     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(02)00525-9     Document Type: Article

References (31)

1. Kawasaki T., Kousaki F. Febrile oculo-oro-cutaneous-arco desquamatous syndrome with or without acute non-suppurative cervical lymphadenitis in infancy and children. Clinical observations of 50 cases. Arerugi. 16:1967;172-222.
2. Fujiwara H., Hamashima Y. Pathology of the heart in Kawasaki disease. Pediatrics. 61:1978;100-107.
3. Kato H., Koike S., Yamamoto M., et al. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 86:1975;892-898.
4. Fujiwara H., Chen C., Fujiwara T., et al. Clinicopathologic study of abnormal Q waves in Kawasaki disease (mucocutaneous lymph node syndrome). An infantile cardiac disease with myocarditis and myocardial infarction. Am J Cardiol. 45:1980;797-804.
5. Kondo C., Hiroe M., Nakanishi T., et al. Detection of coronary artery stenosis in children with Kawasaki disease. Usefulness of pharmacologic stress 201Tl myocardial tomography. Circulation. 80:1989;615-624.
6. Schillaci O., Laganà B., Danieli R., et al. Technetium-99m sestamibi single-photon emission tomography detects subclinical myocardial perfusion abnormalities in patients with systemic lupus erythematosus. Eur J Nucl Med. 26:1999;713-717.
7. Civelek A.C., Kavanaugh-McHugh A., Ozguven M.A., et al. Noninvasive assessment of myocardium at risk by Tl-201 SPECT imaging in a child with Kawasaki disease. A case report. Clin Nucl Med. 17:1992;191-194.
8. Spielmann R.P., Nienaber C.A., Hausdorf G., et al. Tomographic myocardial perfusion scintigraphy in children with Kawasaki disease. J Nucl Med. 28:1987;1839-1843.
9. Jan S.L., Hwang B., Fu Y.C., et al. Comparison of 201Tl SPET and treadmill exercise testing in patients with Kawasaki disease. Nucl Med Commun. 21:2000;431-435.
10. Schillaci O., Banci M., Scopinaro F., et al. Myocardial scintigraphy with 99mTc-sestamibi in children with Kawasaki disease. Angiology. 46:1995;1009-1014.
11. Canhasi B., Dae M., Botvinick E., et al. Interaction of 'supplementary' scintigraphic indicators of ischemia and stress electrocardiography in the diagnosis of multivessel coronary disease. J Am Coll Cardiol. 6:1985;581-588.
12. Nordrehaug J.E., Danielsen R., Vik-Mo H. Physiological inverse relationship between heart rate and thallium-201 lung uptake, clearance and lung/myocardial uptake ratio. Eur Heart J. 11:1990;628-633.
13. Dahdah N.S., Fournier A., Jaeggi E., et al. Segmental myocardial contractility versus perfusion in Kawasaki disease with coronary arterial aneurysm. Am J Cardiol. 83:1999;48-51.
14. Hijazi Z.M., Udelson J.E., Snapper H., et al. Physiologic significance of chronic coronary aneurysms in patients with Kawasaki disease. J Am Coll Cardiol. 24:1994;1633-1638.
15. Kondo C., Nakanishi T., Sonobe T., et al. Scintigraphic monitoring of coronary artery occlusion due to Kawasaki disease. Am J Cardiol. 71:1993;681-685.
16. Paridon S.M., Galioto F.M., Vincent J.A., et al. Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents. J Am Coll Cardiol. 25:1995;1420-1424.
17. Higley B., Smith F.W., Smith T., et al. Technetium-99m-1,2-bis(bis(2-ethoxyethyl)phosphino)ethane: human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent. J Nucl Med. 34:1993;30-38.
18. Kelly J.D., Forster A.M., Higley B., et al. Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging. J Nucl Med. 34:1993;222-227.
19. Flamen P., Bossuyt A., Franken P.R. Technetium-99m-tetrofosmin in dipyridamole-stress myocardial SPECT imaging: intraindividual comparison with technetium-99m-sestamibi. J Nucl Med. 36:1995;2009-2015.
20. Karasawa K., Ayusawa M., Noto N., et al. Optimum protocol of technetium-99m tetrofosmin myocardial perfusion imaging for the detecting of coronary stenosis lesions in Kawasaki disease. J Cardiol. 30:1997;331-339.
21. Kawasaki T. Agreement with the guidelines by the mucocutaneous lymph node syndrome research committee (in Japanese). Nippon Shonika Gakkai Zasshi. 88:1984;2693.
22. Travin M.I., Katz M.S., Moulton A.W., et al. Accuracy of dipyridamole SPECT imaging in identifying individual coronary stenoses and multivessel disease in women versus men. J Nucl Cardiol. 7:2000;213-220.
23. Kato H., Sugimura T., Akagi T., et al. Long-term consequence of Kawasaki disease: A 10- to 20-year follow-up study of 594 patients. Circulation. 94:1996;1379-1385.
24. Rowley A.H., Shulman S.T. Kawasaki syndrome. Pediatr Clin N Am. 46:1999;313-329.
25. Nienaber C.A., Spielmann R.P., Hausdorf G. Dipyridamole-thallium-201 tomography documenting improved myocardial perfusion with therapy in Kawasaki disease. Am Heart J. 116:1988;1575-1579.
26. Chung J.K., Brandt L., Fulton D.R., et al. Cardiac and coronary arterial involvement in infants and children from New England with mucocutaneous lymph node syndrome (Kawasaki disease). Am J Cardiol. 50:1982;136-139.
27. Satomi G., Nakimura K., Sakae N., et al. Systemic visualization of coronary arteries by two-dimensional echocardiography in children and infants: evaluation in Kawasaki's disease and coronary arteriovenous fistulas. Am Heart J. 107:1984;497-504.
28. Maeda T., Yoshida H., Funabashi T., et al. Subcostal 2-dimensional echocardiographic imaging of peripheral left coronary artery aneurysms in Kawasaki disease. Am J Cardiol. 52:1983;48-52.
29. Kegel S.M., Dorsey T.J., Rowen M., et al. Cardiac death in mucocutaneous lymph node syndrome. Am J Cardiol. 40:1977;282-286.
30. Wiles H.B., Moore W.H., Brickes J.T., et al. Myocardial ischemia in young children with coronary aneurysm after Kawasaki disease (abstract). Circulation. 76:1987;492.
31. Nakano H., Ueda K., Saito A., et al. Repeated quantitative angiograms in coronary arterial aneurysms in Kawasaki disease. Am J Cardiol. 56:1985;846-851.